GSK Investigational Site

Saint Louis Park, Minnesota 55426

0 studies enrolling now · 8 studies all time

What they study most

Bowel Dysfunction, Constipation, Erectile Dysfunction, Lung Cancer, Non-Small Cell, Melanoma, Migraine Disorders, Migraine, Without Aura, Neoplasms, Breast, Severe Acute Respiratory Syndrome

Studies at this site

• Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease — Completed
• A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor — Stopped early
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication — Completed
• A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia — Completed
• TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1) — Completed
• Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks — Completed
• Treatment With Pazopanib for Neoadjuvant Breast Cancer — Completed